Predictive factors of gastroduodenal toxicity in cirrhotic patients after three-dimensional conformal radiotherapy for hepatocellular carcinoma

Radiotherapy and Oncology

Volumn 93, Issue 2, 2009, Pages 302-306

  Kim, Haeyoung ^a   Lim, Do Hoon ^a   Paik, Seung Woon ^a   Yoo, Byung Chul ^a   Koh, Kwang Gheol ^a   Lee, Joon Hyoek ^a   Choi, Moon Seok ^a   Park, Won ^a   Park, Hee Chul ^a   Huh, Seung Jae ^a   Choi, Doo Ho ^a   Ahn, Yong Chan ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Gastroduodenal toxicity; Hepatocellular carcinoma; Three dimensional conformal radiotherapy

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ASSESSMENT; COMPUTER ASSISTED RADIOTHERAPY; DOSE LIVER FUNCTION RELATION; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER FUNCTION TEST; MALE; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; RISK FACTOR; ROC CURVE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DUODENUM; FEMALE; GASTRIC MUCOSA; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES;

EID: 70350519392     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.05.017     Document Type: Article

References (27)

1. Cheng S.H., Lin Y.M., Chuang V.P., et al. A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma. J Gastroenterol Hepatol 14 (1999) 1025-1033
2. Seong J., Park H.C., Han K.H., and Chon C.Y. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 55 (2003) 329-336
3. Li B., Yu J., Wang L., et al. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Am J Clin Oncol 26 (2003) e92-e99
4. Park H.C., Seong J., Han K.H., Chon C.Y., Moon Y.M., and Suh C.O. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 54 (2002) 150-155
5. Park W., Lim D.H., Paik S.W., et al. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1143-1150
6. Dawson L.A., McGinn C.J., Normolle D., et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 18 (2000) 2210-2218
7. Cheng J.C., Wu J.K., Lee P.C., et al. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Int J Radiat Oncol Biol Phys 60 (2004) 1502-1509
8. Kim T.H., Kim D.Y., Park J.W., et al. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 225-231
9. Xu Z.Y., Liang S.X., Zhu J., et al. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 189-195
10. Raoul J.L. Natural history of hepatocellular carcinoma and current treatment options. Semin Nucl Med 38 (2008) S13-S18
11. Tomoda J., Mizuno M., Sugihara T., Itano T., and Tsuji T. Gastric mucosal lesion in liver disease: impaired gastric mucosal defence mechanism in rats with induced liver injury and in patients with liver cirrhosis. J Gastroenterol Hepatol 4 Suppl 1 (1989) 136-139
12. Chen L.S., Lin H.C., Hwang S.J., Lee F.Y., Hou M.C., and Lee S.D. Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J Gastroenterol Hepatol 11 (1996) 59-64
13. Siringo S., Burroughs A.K., Bolondi L., et al. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol 22 (1995) 633-641
14. Trotti A., Byhardt R., and Stetz J. Et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 13-47
15. Robertson J.M., Lawrence T.S., Andrews J.C., Walker S., Kessler M.L., and Ensminger W.D. Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers. Int J Radiat Oncol Biol Phys 37 (1997) 325-330
16. Kitano S., and Dolgor B. Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis?. J Gastroenterol 35 (2000) 79-86
17. Hall E.J., and Giaccia A.J. Radiobiology for the Radiobiologist. 6th ed. (2006), Lippincott Williams & Wilkins, Philadelphia
18. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
19. Baglan K.L., Frazier R.C., Yan D., Huang R.R., Martinez A.A., and Robertson J.M. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 52 (2002) 176-183
20. Tho L.M., Glegg M., Paterson J., et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys 66 (2006) 505-513
21. Peeters S.T., Lebesque J.V., Heemsbergen W.D., et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1151-1161
22. Wachter S., Gerstner N., Goldner G., Potzi R., Wambersie A., and Potter R. Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors. Radiother Oncol 59 (2001) 65-70
23. Huang E.H., Pollack A., Levy L., et al. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54 (2002) 1314-1321
24. van der Laan H.P., van den Bergh A., Schilstra C., Vlasman R., Meertens H., and Langendijk J.A. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 1138-1145
25. Bussels B., Goethals L., Feron M., et al. Respiration-induced movement of the upper abdominal organs: a pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer. Radiother Oncol 68 (2003) 69-74
26. Balter J.M., Brock K.K., Litzenberg D.W., et al. Daily targeting of intrahepatic tumors for radiotherapy. Int J Radiat Oncol Biol Phys 52 (2002) 266-271
27. Kitamura K., Shirato H., Seppenwoolde Y., et al. Tumor location, cirrhosis, and surgical history contribute to tumor movement in the liver, as measured during stereotactic irradiation using a real-time tumor-tracking radiotherapy system. Int J Radiat Oncol Biol Phys 56 (2003) 221-228